Vivoryon Therapeutics N.V. (VVY.AS)
EUR 1.97
(0.71%)
EUR 1.97
(0.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -21.54 Million | -21.79 Million | -11.25 Million | -14.01 Million | -11.6 Million | -6994.00 |
| Net Income | -28.34 Million | -28.15 Million | -12.65 Million | -16.51 Million | -7.82 Million | -7737.00 |
| Depreciation & Amortization | 167 Thousand | 161 Thousand | 165 Thousand | 146 Thousand | 88 Thousand | 23.00 |
| Deferred income taxes | -234 Thousand | -199 Thousand | 3.11 Million | 79.84 Thousand | -409 Thousand | -645.06 Thousand |
| Stock-based compensation | 3.94 Million | 3.48 Million | 1.76 Million | 159 Thousand | 5000.00 | 62 Thousand |
| Change in working capital | -235 Thousand | 207 Thousand | -579 Thousand | 1.68 Million | -3.94 Million | 645 Thousand |
| Other non-cash items | 6.89 Million | 6.18 Million | -1.3 Million | 591 Thousand | 476 Thousand | 720.00 |
| Investing Cash Flow | -10.51 Million | -13 Thousand | -28 Thousand | -640 Thousand | -47 Thousand | 460.00 |
| Investments in PPE | -514 Thousand | -13 Thousand | -28 Thousand | -640 Thousand | -47 Thousand | -16.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -19 Million | - | - | - | - | - |
| Sales/Maturities of investments | 9 Million | - | - | - | - | - |
| Other Investing Activities | -10.5 Million | -2.00 | -8.00 | -576.00 | - | 476.00 |
| Financing Cash Flow | 24.15 Million | 33.38 Million | -827 Thousand | -90 Thousand | 49.35 Million | - |
| Debt repayment | -94 Thousand | -92.00 | -90.00 | -90.00 | -56.00 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 26.34 Million | 35.24 Million | -737 Thousand | - | 49.41 Million | - |
| Other Financing Activities | -2.09 Million | -1.86 Million | -89.91 Thousand | -89.91 Thousand | -55.94 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 538 Thousand | -1.81 Million | 3.44 Million | 372 Thousand | -233 Thousand | 418 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -773 Thousand | 2.02 Million | -4.02 Million | 1.3 Million | -3.7 Million | 227 Thousand |
| Cash at beginning of period | 26.55 Million | 14.66 Million | 26.3 Million | 41.52 Million | 3.78 Million | 10.29 Thousand |
| Cash at end of period | 18.56 Million | 26.55 Million | 14.66 Million | 26.3 Million | 41.52 Million | 3783.00 |
| Capital Expenditure | -514 Thousand | -13 Thousand | -28 Thousand | -640 Thousand | -47 Thousand | -16.00 |
| Effect of forex changes on cash | -95 Thousand | 320.00 | 467.00 | -476.00 | 41.00 | 26.00 |
| Net cash flow / Change in cash | -7.99 Million | 11.89 Million | -11.64 Million | -15.21 Million | 37.74 Million | -6508.00 |
| Free Cash Flow | -22.05 Million | -21.8 Million | -11.28 Million | -14.65 Million | -11.65 Million | -7010.00 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.55 Million | -28.34 Million | -17.62 Million | -10.71 Million | -28.15 Million | -15.57 Million |
| Depreciation & Amortization | 73 Thousand | 167 Thousand | 88 Thousand | 79 Thousand | 161 Thousand | 80 Thousand |
| Deferred income taxes | - | -234 Thousand | -189 Thousand | -45 Thousand | -199 Thousand | -199 Thousand |
| Stock-based compensation | 1.21 Million | 3.94 Million | 1.63 Million | 2.3 Million | 3.48 Million | 2.45 Million |
| Change in working capital | 300 Thousand | -235 Thousand | 9.9 Million | -11.93 Million | 207 Thousand | -1.05 Million |
| Other non-cash items | -1.33 Million | 6.89 Million | 4.73 Million | 3.43 Million | 6.18 Million | 5.98 Million |
| Investing Cash Flow | 10 Million | -10.51 Million | -10.5 Million | -9000.00 | -13 Thousand | -11 Thousand |
| Investments in PPE | - | -514 Thousand | -5000.00 | -9000.00 | -13 Thousand | -9000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -19 Million | -19 Million | - | - | - |
| Sales/Maturities of investments | 10 Million | 9 Million | 9 Million | - | - | - |
| Other Investing Activities | 10 Million | -10.5 Million | -10.5 Million | - | -2.00 | -2000.00 |
| Financing Cash Flow | -28 Thousand | 24.15 Million | 757 Thousand | 23.4 Million | 33.38 Million | 13.8 Million |
| Debt repayment | -28 Thousand | -94 Thousand | - | -47 Thousand | -92.00 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 26.34 Million | 2.89 Million | 23.44 Million | 35.24 Million | 15.62 Million |
| Other Financing Activities | -28 Thousand | -2.09 Million | 757 Thousand | 23.44 Million | -1.86 Million | -1.77 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.44 Million | 538 Thousand | 1.48 Million | -946 Thousand | -1.81 Million | -634 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 300 Thousand | -773 Thousand | 9.9 Million | -10.98 Million | 2.02 Million | -423 Thousand |
| Cash at beginning of period | 18.56 Million | 26.55 Million | 29.58 Million | 26.55 Million | 14.66 Million | 24.38 Million |
| Cash at end of period | 15.27 Million | 18.56 Million | 18.56 Million | 29.58 Million | 26.55 Million | 26.55 Million |
| Capital Expenditure | - | -514 Thousand | -5000.00 | -9000.00 | -13 Thousand | -9000.00 |
| Effect of forex changes on cash | 38 Thousand | -95 Thousand | -13 Thousand | -82 Thousand | 320.00 | -60 Thousand |
| Net cash flow / Change in cash | -3.29 Million | -7.99 Million | -11.02 Million | 3.02 Million | 11.89 Million | 2.17 Million |
| Free Cash Flow | -13.3 Million | -22.05 Million | -1.26 Million | -20.29 Million | -21.8 Million | -11.56 Million |
MKC
IMM
ACO-Y
GLOSTERLTD
SHIP
TGTX